PMDL — Pace Medical Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Pace Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2001 December 31st | 2002 December 31st | 2003 December 31st | 2004 December 31st | 2005 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.55 | 1.21 | 1.32 | 1.22 | 1.45 |
| Cost of Revenue | |||||
| Gross Profit | 0.763 | 0.582 | 0.485 | 0.553 | 0.813 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 1.6 | 1.4 | 1.69 | 1.53 | 1.63 |
| Operating Profit | -0.049 | -0.195 | -0.367 | -0.318 | -0.185 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0 | -0.166 | -0.344 | -0.294 | -0.146 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.038 | -0.197 | -0.376 | -0.309 | -0.187 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.038 | -0.197 | -0.376 | -0.309 | -0.187 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.038 | -0.197 | -0.376 | -0.309 | -0.187 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.011 | -0.059 | -0.112 | -0.092 | -0.05 |
| Dividends per Share |